
Skin Cancer Dermatology Market by Test (Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy), Age Group (0-19, 20-39, 40-59), Facility Type - Global Forecast 2024-2030
Description
Skin Cancer Dermatology Market by Test (Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy), Age Group (0-19, 20-39, 40-59), Facility Type - Global Forecast 2024-2030
The Skin Cancer Dermatology Market size was estimated at USD 7.78 billion in 2023 and expected to reach USD 8.42 billion in 2024, at a CAGR 7.40% to reach USD 12.83 billion by 2030.
Global Skin Cancer Dermatology Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Skin Cancer Dermatology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Skin Cancer Dermatology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Skin Cancer Dermatology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb Company, Canfield Scientific, Inc., Colleyville Dermatology, Cutera, Inc., FotoFinder Systems, Inc., Merck & Co., Inc., MetaOptima Technology Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Skin Analytics Pty Ltd., Speclipse, Inc., and Sun Pharmaceutical Industries Limited.
Market Segmentation & Coverage
This research report categorizes the Skin Cancer Dermatology Market to forecast the revenues and analyze trends in each of the following sub-markets:
Test
Dermatoscopy
Diagnostic Imaging
Lymph Node Biopsy
Skin Biopsy
Age Group
0-19
20-39
40-59
60-64
65-74
75-84
85 & Above
Facility Type
Dermatology Group
Hospital OPD
Multispecialty Clinics
Stand Alone Practices
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Skin Cancer Dermatology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Skin Cancer Dermatology Market?
3. What are the technology trends and regulatory frameworks in the Skin Cancer Dermatology Market?
4. What is the market share of the leading vendors in the Skin Cancer Dermatology Market?
5. Which modes and strategic moves are suitable for entering the Skin Cancer Dermatology Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
190 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Skin Cancer Dermatology Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing incidences of skin cancer worldwide
- 5.1.1.2. Availability of advanced healthcare infrastructure
- 5.1.1.3. Rising awareness about skin cancer among the population
- 5.1.2. Restraints
- 5.1.2.1. Capital intensive treatment with therapy
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing development with introduction of teledermatology
- 5.1.3.2. Increasing number of smartphone-compatible diagnostic devices
- 5.1.4. Challenges
- 5.1.4.1. Strict regulatory framework for the approval and treatment
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Skin Cancer Dermatology Market, by Test
- 6.1. Introduction
- 6.2. Dermatoscopy
- 6.3. Diagnostic Imaging
- 6.4. Lymph Node Biopsy
- 6.5. Skin Biopsy
- 7. Skin Cancer Dermatology Market, by Age Group
- 7.1. Introduction
- 7.2. 0-19
- 7.3. 20-39
- 7.4. 40-59
- 7.5. 60-64
- 7.6. 65-74
- 7.7. 75-84
- 7.8. 85 & Above
- 8. Skin Cancer Dermatology Market, by Facility Type
- 8.1. Introduction
- 8.2. Dermatology Group
- 8.3. Hospital OPD
- 8.4. Multispecialty Clinics
- 8.5. Stand Alone Practices
- 9. Americas Skin Cancer Dermatology Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Skin Cancer Dermatology Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Skin Cancer Dermatology Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Amgen, Inc.
- 13.1.3. Bristol-Myers Squibb Company
- 13.1.4. Canfield Scientific, Inc.
- 13.1.5. Colleyville Dermatology
- 13.1.6. Cutera, Inc.
- 13.1.7. FotoFinder Systems, Inc.
- 13.1.8. Merck & Co., Inc.
- 13.1.9. MetaOptima Technology Inc.
- 13.1.10. Novartis AG
- 13.1.11. Pfizer Inc.
- 13.1.12. Regeneron Pharmaceuticals, Inc.
- 13.1.13. Sanofi S.A.
- 13.1.14. Skin Analytics Pty Ltd.
- 13.1.15. Speclipse, Inc.
- 13.1.16. Sun Pharmaceutical Industries Limited
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. SKIN CANCER DERMATOLOGY MARKET RESEARCH PROCESS
- FIGURE 2. SKIN CANCER DERMATOLOGY MARKET SIZE, 2023 VS 2030
- FIGURE 3. SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. SKIN CANCER DERMATOLOGY MARKET DYNAMICS
- FIGURE 7. SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2030 (%)
- FIGURE 8. SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
- FIGURE 10. SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2030 (%)
- FIGURE 12. SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.